Evaluation of three population-based strategies for fracture prevention: Results of the Osteoporosis Population-Based Risk Assessment (OPRA) trial

Medical Care

Volumn 43, Issue 3, 2005, Pages 293-302

  LaCroix, Andrea Z ^a,b   Buist, Diana S M ^a   Brenneman, Susan K ^c   Abbott III, Thomas A ^c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bone density testing; Fracture prevention; Osteoporosis screening programs

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; HEALTH PROGRAM; HIP FRACTURE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOMES RESEARCH; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DENSITOMETRY; HEALTH MAINTENANCE ORGANIZATION; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; BONE DENSITY; DENSITOMETRY; FEMALE; FRACTURES, BONE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH MAINTENANCE ORGANIZATIONS; HIP FRACTURES; HUMANS; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS; QUESTIONNAIRES; RISK ASSESSMENT; TREATMENT OUTCOME; WASHINGTON;

EID: 14844290326     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200503000-00012     Document Type: Article

References (31)

1. National Center for Health Statistics. Health, United States, 2001 with Urban and Rural Health Chartbook. Hyattsville, MD: Dept of Health and Human Services; 2001. Publication (PHS) 01-1232.
2. US Department of Health and Human Services. Washington, DC: Public Health Service (91-50212), U.S. Government Printing Office; 1991.
3. Greendale GA, Barrett-Connor E. Outcomes of osteoporotic fractures. In: Marcus R, Freedman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press; 1996:635-644.
4. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12:24-35.
5. Slemenda CW, Johnston CC, Hui LH. Assessing fracture risk. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press; 1996:623-633.
6. Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med. 1992;116:990-995.
7. Pressman A, Forsyth B, Ettinger B, et al. Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int. 2001;12: 337-342.
8. Solomon DH, Levin E, Helfgott SM. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment. J Rheumatol. 2000;27:1496-1500.
9. Fitt NS, Mitchell SL, Cranney A, et al. Influence of bone densitometry results on the treatment of osteoporosis. CMAJ. 2001;164:777-781.
10. Silverman SL, Greenwald M, Klein RA, et al. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol. 1997;89:321-325.
11. Rolnick SJ, Kopher R, Jackson J, et al. What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting? Menopause. 2001;8:141-148.
12. Taplin SH, Mandelson MT, Anderman C, et al. Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev. 1997;6:625-631.
13. Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manage Care. 1998;4:37-48.
14. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-773.
15. Buist DS, LaCroix AZ, Manfredonia D, et al. Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies. J Am Geriatr Soc. 2002;50:1031-1038.
16. Cadarette SM, Jaglal SB, Murray TM, et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA. 2001;286:57-63.
17. Melton LJ 3rd. Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res. 2000;15:2309-2314.
18. Garton MJ, Cooper C, Reid D. Perimenopausal bone density screening - will it help prevent osteoporosis? Maturitas. 1997;26:35-43.
19. Holt LT, Taft LB, Moulthrop JM. Bone density measurement: survey of use and impact on treatment. Menopause. 1997;4:219-224.
20. Jones G, Scott F. Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program. J Clin Densitom. 1999;2:109-115.
21. Marci CD, Anderson WB, Viechnicki MB, et al. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int. 2000;66:113-118.
22. Jamal SA, Ridout R, Chase C, et al. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res. 1999;14:2143-9.
23. Papaioannou A, Parkinson W, Adachi J, et al. Women's decisions about hormone replacement therapy after education and bone densitometry. CMAJ. 1998;159:1253-1257.
24. Korn LM, Powe NR, Levine, et al. Is screening for osteoporosis associated with fewer hip fractures? J Gen Intern Med. 2002:144.
25. Buist DSM, LaCroix AZ, Brenneman SK, et al. A population-based osteoporosis screening program: who does not participate and what are the consequences? JAGS. 2004;52:1130-1137.
26. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280: 2077-2082.
27. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-340.
28. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613.
29. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
30. Grady D, Cummings SR. Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? JAMA. 2001;285:2909-2910.
31. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137:526-528.